S&P Futures
4,405.75-8.50(-0.19%)Dow Futures
34,953.00-81.00(-0.23%)Nasdaq Futures
15,099.50-18.25(-0.12%)Russell 2000 Futures
2,203.40-10.00(-0.45%)Crude Oil
71.89-0.02(-0.03%)Gold
1,794.30-4.90(-0.27%)
Chart Events
Performance Outlook
| Previous Close | 471.22 |
| Open | 469.49 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's Range | 464.57 - 472.51 |
| 52 Week Range | 370.22 - 475.44 |
| Volume | 632,247 |
| Avg. Volume | 776,565 |
| Market Cap | 60.29B |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | 16.60 |
| EPS (TTM) | 28.15 |
| Earnings Date | Jul 28, 2021 |
| Forward Dividend & Yield | 2.80 (0.60%) |
| Ex-Dividend Date | Jun 29, 2021 |
| 1y Target Est | 489.14 |
- Zacks
Humana (HUM) to Announce Q2 Earnings: Here's What to Expect
Humana's (HUM) second-quarter earnings results to reflect a steep expense level, partly offset by better revenues.
- Zacks
Analysts Estimate Humana (HUM) to Report a Decline in Earnings: What to Look Out for
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
XSOLIS Collaborates with Humana on New Approach to Utilization Management
XSOLIS, the company solving operational challenges in healthcare, is partnering with Humana Inc., a leading health and well-being company, to offer its real-time, predictive analytics platform for utilization review processes between Humana and participating providers. Alongside and in collaboration with participating XSOLIS client health systems, Humana will be adopting Precision Utilization Management (Precision UM), a process by which XSOLIS analytics identify and stratify a subset of member
